Abstract
Fibrillar aggregates of Aβ peptides and tau protein are defining features of Alzheimer's disease (AD) and evidence is accumulating that peptide conformation within fibrils correlates with disease subtype. Nevertheless, high resolution structures of fibrillar polymorphs fall short of defining the molecular mechanisms underlying disease. Mapping of the spatial distribution of polymorphs at multiple length scales—within plaques and tangles, across brain tissue, and in multiple brain regions—is being carried out to supplement high resolution information.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
